PFE,KMX Stock Quote

PFE [NYSE]

Healthcare | Drug Manufacturers - General | USA

Index	S&P 500	P/E	20.54	EPS (ttm)	1.67	Insider Own	0.05%	Shs Outstand	5.56B	Perf Week	1.12%
Market Cap	192.02B	Forward P/E	11.16	EPS next Y	3.06	Insider Trans	-6.39%	Shs Float	5.55B	Perf Month	-2.26%
Income	9.36B	PEG	3.05	EPS next Q	0.79	Inst Own	67.60%	Short Float	1.14%	Perf Quarter	-13.22%
Sales	47.64B	P/S	4.03	EPS this Y	-33.10%	Inst Trans	-	Short Ratio	1.58	Perf Half Y	-2.15%
Book/sh	11.71	P/B	2.92	EPS next Y	-7.21%	ROA	5.70%	Target Price	41.09	Perf Year	-0.86%
Cash/sh	2.18	P/C	15.71	EPS next 5Y	6.73%	ROE	14.90%	52W Range	26.42 - 43.08	Perf YTD	-7.09%
Dividend	1.56	P/FCF	51.74	EPS past 5Y	2.20%	ROI	7.60%	52W High	-20.61%	Beta	0.67
Dividend %	4.56%	Quick Ratio	1.00	Sales past 5Y	-3.00%	Gross Margin	79.10%	52W Low	29.44%	ATR	0.61
Employees	78500	Current Ratio	1.40	Sales Q/Q	11.80%	Oper. Margin	15.70%	RSI (14)	42.39	Volatility	2.15% 1.42%
Optionable	Yes	Debt/Eq	0.63	EPS Q/Q	125.10%	Profit Margin	20.20%	Rel Volume	1.13	Prev Close	34.39
Shortable	Yes	LT Debt/Eq	0.59	Earnings	Feb 02 BMO	Payout	87.90%	Avg Volume	39.92M	Price	34.20
Recom	2.60	SMA20	-0.54%	SMA50	-4.56%	SMA200	-3.36%	Volume	45,191,481	Change	-0.55%

Feb-04-21

Upgrade

DZ Bank

Hold → Buy

$41

Dec-16-20

Downgrade

RBC Capital Mkts

Outperform → Sector Perform

$43 → $42

Nov-19-20

Resumed

Goldman

Neutral

$40

Nov-10-20

Resumed

Bernstein

Mkt Perform

$42

Oct-12-20

Downgrade

Atlantic Equities

Overweight → Neutral

$44 → $39

Sep-29-20

Initiated

Berenberg

Hold

$38

Jun-16-20

Initiated

SVB Leerink

Mkt Perform

$40

Feb-27-20

Upgrade

Standpoint Research

Hold → Buy

Feb-27-20

Initiated

Barclays

Equal Weight

$36

Feb-06-20

Initiated

Mizuho

Buy

Jan-07-20

Initiated

RBC Capital Mkts

Outperform

$46

Oct-17-19

Resumed

BofA/Merrill

Neutral

$37

Jul-30-19

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$48 → $40

Jul-30-19

Downgrade

BofA/Merrill

Buy → Neutral

Jun-04-19

Resumed

Morgan Stanley

Overweight

$48

Feb-20-19

Resumed

Citigroup

Neutral

$41

Jan-31-19

Upgrade

Credit Suisse

Neutral → Outperform

Jan-31-19

Upgrade

Argus

Hold → Buy

Jan-23-19

Downgrade

UBS

Buy → Neutral

Dec-11-18

Downgrade

JP Morgan

Overweight → Neutral

Mar-05-21 02:12AM	UPDATE 1-Japan's Takeda seeks govt approval for Moderna COVID-19 vaccine Reuters
01:52AM	German Cases Hit Highest in a Month; Tokyo Extends: Virus Update Bloomberg
Mar-04-21 07:01PM	COVID-19 vaccine confidence grows as side effect worries fade Reuters
05:45PM	Pfizer (PFE) Stock Moves -0.55%: What You Should Know Zacks
03:57PM	Coronavirus vaccine scams are on the rise here's how to spot them Yahoo Finance
02:44PM	Songlorious platform brings income to musicians amid the pandemic Yahoo Finance Video
02:32PM	Its a split field in Texas over lifted mask mandate: Fort Worth Mayor Yahoo Finance Video
02:06PM	Doctor: Texas removing the mask mandate was way too soon and rather foolish Yahoo Finance Video
11:30AM	Pfizer (PFE) Down 1.3% Since Last Earnings Report: Can It Rebound? Zacks
11:09AM	UPDATE 3-S.Africa regulator says at advanced stage of Pfizer vaccine review Reuters
11:01AM	UPDATE 2-Israel, Austria and Denmark establish vaccine-supply alliance Reuters
10:17AM	Novartis Will Help Manufacture CureVacs Covid-19 Vaccine Barrons.com
10:10AM	Biotech current stock performance is actually pretty rational: analyst Yahoo Finance Video
10:00AM	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire
08:41AM	Pfizer's (PFE) Lorbrena Gets FDA Nod for First-Line Lung Cancer Zacks
08:22AM	Study Reports Some Cases Of Delayed Rash After Moderna COVID-19 Vaccine Dose: Report Benzinga
08:12AM	The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company Benzinga
07:27AM	UPDATE 2-Germany approves AstraZeneca for over-65s, extends gap between doses Reuters
06:23AM	Pfizer's Lorbrena Wins Full FDA Approval As First Line Treatment Of ALK-Positive Lung Cancer Benzinga
06:12AM	How Will Johnson & Johnson's COVID Vaccine Shake Up the Market? Motley Fool
01:00AM	UK regulator says will fast-track vaccines for coronavirus variants Reuters
Mar-03-21 07:03PM	U.S. FDA Expands Approval of Pfizers LORBRENA® as First-Line Treatment for ALK-Positive Metastatic Lung Cancer Business Wire
03:16PM	King Arthur Baking Company sees flour sales up 58% year-over-year amid pandemic Yahoo Finance Video
03:02PM	COVID SCIENCE-T cell response to virus variants remains potent; Asthma does not raise severe COVID-19 risk Reuters
02:35PM	Senate expected to begin stimulus debate today Yahoo Finance Video
02:18PM	Doctor: Health care workers are frustrated and concerned over lifting of virus mandates Yahoo Finance Video
12:25PM	UPDATE 1-Faster vaccination needed in Latam to curb rise of dangerous variants, PAHO says Reuters
12:05PM	Novavax Under Pressure As It Guides To Vaccine Data; Is NVAX Stock A Buy? Investor's Business Daily
11:49AM	Cramer Advises Viewers On Palo Alto, Pfizer, Zillow And More Benzinga
10:47AM	Analyzing Pfizer's Unusual Options Activity Benzinga
08:53AM	U.S. Vaccine Shortage Could Soon End With Oversupply Barrons.com
08:46AM	Biden Says U.S. Could Have Enough Vaccine Doses for Every American in May Barrons.com
07:44AM	EU regulator not budging on vaccine dosage as states scramble for shots Reuters
07:13AM	EU Considers Emergency Approvals To Boost COVID-19 Vaccine Rollout: Reuters Benzinga
06:14AM	Here's What the FDA Liked About Johnson & Johnson's COVID Vaccine Motley Fool
05:47AM	Interim UK study finds one dose of COVID shots reduces hospitalisation Reuters
03:02AM	'Mad Money' Lightning Round: Oracle, Zillow, Pfizer and more TheStreet.com
02:33AM	UPDATE 2-S.Korea investigates deaths of two who received AstraZeneca COVID-19 vaccine Reuters
Mar-02-21 06:00PM	Merck Stepping In To Help JNJ With Covid Vaccine In 'Wartime Effort' Investor's Business Daily
03:51PM	Doctor endorses J&J's COVID-19 shot, all 3 vaccines a 'path to ending the pandemic' Yahoo Finance
01:24PM	Doctor: Even as vaccines progress we cant let our guard down Yahoo Finance Video
12:12PM	J&J single-dose vaccine is 'absolutely' a game changer: physician Yahoo Finance
12:08PM	25 stocks of companies backed by rapid earnings growth as the economy reopens MarketWatch
11:51AM	Renishaw shares soar 18% as engineer puts itself up for sale MarketWatch
11:46AM	Coronavirus update: Merck to produce J&J vaccines; CDC launches vaccine finder Yahoo Finance
10:58AM	Merck Will Help Make J&Js Covid-19 Vaccine, Washington Post Reports Barrons.com
10:36AM	AstraZenecas Vaccine Works in Older Adults, UK Says Barrons.com
10:32AM	U.S. COVID vaccine supply to be boosted by Merck helping make J&J vaccine MarketWatch
08:44AM	People Allergic To Pfizer, Moderna COVID-19 Vaccine Might Be Allowed To Get JNJ Shot: CNBC Benzinga
08:18AM	UPDATE 1-France uses only quarter of Astrazeneca vaccine doses-ministry Reuters
08:11AM	Where Will Pfizer Be in 1 Year? Motley Fool
07:59AM	Single dose of AstraZeneca or Pfizer COVID-19 vaccine cuts hospitalization risk by more than 80%, study shows MarketWatch
07:18AM	The Zacks Analyst Blog Highlights: Johnson & Johnson, Pfizer, BioNTech, Moderna and AstraZeneca Zacks
07:00AM	Is Pfizer Stock A Buy As The Company Bolsters Its Covid Vaccine Supply? Investor's Business Daily
07:00AM	Strata Oncology Announces the Strata PATH Trial with Pfizer as First Pharma Partner PR Newswire
06:58AM	Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use Reuters
06:49AM	UPDATE 1-Woman dies from brain haemorrhage in Japan days after vaccine, but link uncertain Reuters
06:05AM	Could Coronavirus Variants Boost Pfizer's Vaccine Sales By 50%? Motley Fool
06:02AM	UPDATE 1-France changes tack and approves AstraZeneca shots for under-75s Reuters
04:35AM	UPDATE 1-UK rollout data on AstraZeneca shot should guide other countries -vaccine chief Reuters
02:56AM	S.Korea says up to medical personnel to extract extra doses of COVID vaccine from vial Reuters
Mar-01-21 11:15PM	UPDATE 1-Fauci says U.S. must stick to two-shot strategy for Pfizer, Moderna COVID-19 vaccines - paper Reuters
07:17PM	Novavax Hopes to Start Supplying Covid Shots This Spring Barrons.com
05:14PM	Novavax CEO on COVID-19 vaccine trial progress Yahoo Finance Video
04:18PM	JNJ Stock Rises In Buy Zone As U.S. Begins Distributing Third Covid Vaccine Investor's Business Daily
04:16PM	Vaccine Acceptance Rises As Americans Eye Covid Mutations: IBD/TIPP Poll Investor's Business Daily
02:59PM	France eases ban on AstraZeneca vaccine for over-65s Reuters
01:56PM	Israel to start vaccinating those who recovered from COVID-19 Reuters
12:48PM	Citi, BofA Jump as Mayo Asks Whats Not to Like at Big Banks? Bloomberg
12:45PM	UPDATE 2-UK finds vaccines 80% effective at preventing hospitalisations in over-80s Reuters
12:39PM	J&J CEO: 'We're doing this for the long run' Yahoo Finance
11:07AM	J&J to roll-out single-shot COVID-19 vaccine this week Yahoo Finance Video
10:32AM	J&J CEO says Americans should start getting single-dose COVID vaccine within 48 hours MarketWatch
10:27AM	Johnson & Johnsons Vaccine Will Start Arriving on Tuesday Barrons.com
08:54AM	FDA Emergency Nod for J&J COVID-19 Vaccine Heats Up Competition Zacks
08:38AM	Fauci Urges Americans to Take Johnson & Johnson Vaccine Despite Concerns Barrons.com
08:21AM	J&Js Covid-19 Vaccine Is Authorized. Heres What It Means for the Stock. Barrons.com
07:56AM	Flowserve supplying pumps, valves for Pfizer vaccine production Reuters
07:43AM	UPDATE 1-Flowserve supplying pumps, valves for Pfizer vaccine production Reuters
07:15AM	South Africa Variant Flummoxes AstraZeneca Vaccine; Is AZN Stock A Buy? Investor's Business Daily
06:01AM	INSIGHT-Amid scramble for COVID-19 vaccine, Latin America turns to Russia Reuters
06:00AM	Montreal's Olympic Stadium opens to vaccinating elderly as Canada plays catch-up Reuters
01:13AM	Johnson & Johnson Shares Leap After FDA, CDC Coronavirus Vaccine Approvals TheStreet.com
Feb-28-21 04:57PM	Panama to buy 2 million more doses of Pfizer vaccine Reuters
01:55PM	U.S. administers 75.2 mln doses of COVID-19 vaccines - CDC Reuters
09:37AM	UPDATE 3-Fauci urges Americans to get any of the three COVID-19 vaccines available Reuters
09:22AM	UPDATE 4-Israel plans COVID jabs for Palestinian labourers and settlement workers Reuters
06:01AM	3 Reasons to Buy Pfizer and 1 Reason to Sell Motley Fool
Feb-27-21 08:22PM	FDA Issues Emergency Use Authorization for J&J Covid-19 Vaccine Barrons.com
06:39PM	UPDATE 3-U.S. authorizes J&J's COVID-19 vaccine, making it third available Reuters
06:25PM	EXPLAINER-What J&J's authorized COVID-19 shot means for the U.S. vaccination campaign Reuters
06:19PM	U.S. authorizes Johnson & Johnson's COVID-19 vaccine Reuters
04:19PM	Big Shorts Michael Burry Is Betting On These 11 Stocks Insider Monkey
02:34PM	Johnson & Johnson's COVID-19 Vaccine Is Cleared by the FDA TheStreet.com
02:11PM	U.S. administers 72.8 mln doses of COVID-19 vaccines -CDC Reuters
08:17AM	Johnson & Johnson's Vaccine Gets Unanimous Backing Of FDA Panel, Emergency-Use Authorization Soon To Come Benzinga
Feb-26-21 08:56PM	South Korea vaccinates 18,000 to start ambitious COVID-19 campaign Reuters
07:24PM	The Pandemic Tested Healthcare R&D. Now the Future Looks Bright. Barrons.com
05:54PM	FDA Committee Votes in Favor Of Johnson & Johnsons Covid-19 Vaccine Barrons.com
05:44PM	Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning Investor's Business Daily

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Myovant Sciences Ltd., Akcea Therapeutics, Inc, Verily Life Sciences LLC, Merck KGaA, Valneva SE, IDEAYA Biosciences, Inc., BioNTech SE, Jiangsu Alphamab Biopharmaceuticals Co., Ltd, BioInvent International AB, Sosei Group Corporation, LianBio, and Imcyse S.A. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MACKENZIE ALEXANDER R	Executive Vice President	Feb 27	Option Exercise	22.35	29,838	666,879	153,338	Mar 02 05:59 PM
JOHNSON RADY A	Executive Vice President	Feb 27	Option Exercise	22.35	25,165	562,438	95,309	Mar 02 05:59 PM
SUSMAN SALLY	Executive Vice President	Feb 27	Option Exercise	22.35	71,899	1,606,943	193,474	Mar 02 05:59 PM
YOUNG JOHN D	Group President	Feb 27	Option Exercise	22.35	129,419	2,892,515	575,282	Mar 02 05:59 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27	Option Exercise	22.35	53,925	1,205,224	150,172	Mar 02 06:00 PM
BOURLA ALBERT	Chairman & CEO	Feb 27	Option Exercise	22.35	53,925	1,205,224	165,034	Mar 02 05:34 PM
Carapezzi William R JR	Executive Vice President	Feb 27	Option Exercise	22.35	21,570	482,090	72,522	Mar 02 05:35 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27	Option Exercise	22.35	9,886	220,952	23,745	Mar 02 05:35 PM
DAMELIO FRANK A	Executive Vice President	Feb 27	Option Exercise	22.35	152,785	3,414,745	607,441	Mar 02 05:35 PM
Hwang Angela	Group President	Feb 27	Option Exercise	22.35	9,886	220,952	34,211	Mar 02 05:35 PM
SAHNI PAYAL	Executive Vice President	Feb 25	Option Exercise	22.89	9,982	228,488	22,949	Mar 01 04:10 PM
YOUNG JOHN D	Group President	Feb 25	Option Exercise	22.89	163,334	3,738,715	579,791	Mar 01 04:10 PM
SUSMAN SALLY	Executive Vice President	Feb 25	Option Exercise	22.89	81,667	1,869,358	189,763	Mar 01 04:10 PM
JOHNSON RADY A	Executive Vice President	Feb 25	Option Exercise	22.89	37,658	861,992	100,937	Mar 01 04:05 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 25	Option Exercise	22.89	99,816	2,284,788	178,092	Mar 01 04:05 PM
Hwang Angela	Group President	Feb 25	Option Exercise	22.89	22,686	519,283	42,927	Mar 01 04:01 PM
BOURLA ALBERT	Chairman & CEO	Feb 25	Option Exercise	22.86	163,334	3,733,815	245,037	Mar 01 03:58 PM
Carapezzi William R JR	Executive Vice President	Feb 25	Option Exercise	22.89	27,222	623,112	71,553	Mar 01 03:58 PM
DAMELIO FRANK A	Executive Vice President	Feb 25	Option Exercise	22.89	163,334	3,738,715	588,584	Mar 01 03:58 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 25	Option Exercise	22.89	12,477	285,599	19,781	Mar 01 03:55 PM
BOURLA ALBERT	Chairman & CEO	Nov 09	Sale	41.94	132,508	5,557,386	78,273	Nov 10 05:55 PM
SUSMAN SALLY	Executive Vice President	Nov 09	Sale	41.94	43,662	1,831,184	108,096	Nov 10 05:55 PM
PFIZER INC	10% Owner	Oct 27	Buy	10.00	1,200,000	12,000,000	27,349,211	Oct 29 05:44 PM
BLAYLOCK RONALD E	Director	Aug 06	Buy	38.55	13,000	501,085	13,000	Aug 10 08:07 AM
DAMICO JENNIFER B.	SVP & Controller	Jun 05	Sale	36.13	2,181	78,800	7,542	Jun 08 04:29 PM
Dolsten Mikael	President R&D	May 18	Sale	37.78	95,353	3,602,681	174,918	May 19 05:37 PM
DAMICO JENNIFER B.	SVP & Controller	Apr 29	Sale	38.35	2,181	83,641	9,647	May 01 03:56 PM
JOHNSON RADY A	Executive Vice President	Apr 29	Sale	38.36	13,125	503,475	63,940	May 01 03:56 PM
ROGERS DAWN	Executive Vice President	Apr 29	Sale	38.13	13,000	495,690	4,823	May 01 03:56 PM
LANKLER DOUGLAS M	Executive Vice President	Apr 29	Sale	37.85	65,000	2,460,372	78,276	May 01 03:56 PM
PFIZER INC	10% Owner	Mar 16	Buy	16.00	312,500	5,000,000	1,481,719	Mar 16 07:15 PM

open in screener | open in yahoo | open in reuters | open in google

publish chart | save to portfolio | create alert

KMX [NYSE]

CarMax, Inc.

Consumer Cyclical | Auto & Truck Dealerships | USA

statements

Index	S&P 500	P/E	26.52	EPS (ttm)	4.54	Insider Own	0.10%	Shs Outstand	163.73M	Perf Week	1.16%
Market Cap	19.46B	Forward P/E	21.07	EPS next Y	5.71	Insider Trans	-71.87%	Shs Float	162.04M	Perf Month	-2.23%
Income	751.90M	PEG	4.18	EPS next Q	1.28	Inst Own	99.80%	Short Float	3.55%	Perf Quarter	25.13%
Sales	18.75B	P/S	1.04	EPS this Y	11.20%	Inst Trans	-0.82%	Short Ratio	3.73	Perf Half Y	10.79%
Book/sh	25.21	P/B	4.77	EPS next Y	27.09%	ROA	3.60%	Target Price	124.62	Perf Year	32.64%
Cash/sh	1.46	P/C	82.24	EPS next 5Y	6.34%	ROE	19.50%	52W Range	37.59 - 128.58	Perf YTD	27.36%
Dividend	-	P/FCF	35.83	EPS past 5Y	14.30%	ROI	4.60%	52W High	-6.44%	Beta	1.66
Dividend %	-	Quick Ratio	0.70	Sales past 5Y	7.30%	Gross Margin	12.90%	52W Low	220.03%	ATR	3.64
Employees	27050	Current Ratio	2.60	Sales Q/Q	8.20%	Oper. Margin	5.20%	RSI (14)	51.81	Volatility	2.81% 2.48%
Optionable	Yes	Debt/Eq	3.64	EPS Q/Q	36.50%	Profit Margin	4.00%	Rel Volume	0.54	Prev Close	121.80
Shortable	Yes	LT Debt/Eq	3.53	Earnings	Dec 22 BMO	Payout	0.00%	Avg Volume	1.54M	Price	120.30
Recom	1.60	SMA20	-1.97%	SMA50	6.50%	SMA200	20.43%	Volume	828,253	Change	-1.23%

Jan-19-21

Upgrade

Northcoast

Neutral → Buy

$130

Dec-09-20

Downgrade

JP Morgan

Overweight → Neutral

$115

Oct-19-20

Initiated

Seaport Global Securities

Buy

$113

Oct-05-20

Initiated

Exane BNP Paribas

Underperform

Jun-01-20

Initiated

JP Morgan

Overweight

$105

May-12-20

Upgrade

Wedbush

Neutral → Outperform

$70 → $90

Feb-07-20

Initiated

Evercore ISI

Outperform

Feb-06-20

Initiated

Evercore ISI

Outperform

Jun-28-19

Initiated

Argus

Buy

$100

Jun-28-19

Downgrade

Northcoast

Buy → Neutral

Jun-24-19

Downgrade

Buckingham Research

Buy → Neutral

$94

Apr-01-19

Upgrade

Stephens

Equal-Weight → Overweight

$83 → $93

Jan-07-19

Upgrade

Buckingham Research

Neutral → Buy

Dec-24-18

Upgrade

Guggenheim

Neutral → Buy

Oct-02-18

Initiated

Wolfe Research

Peer Perform

Sep-27-18

Upgrade

Robert W. Baird

Neutral → Outperform

Jul-10-18

Upgrade

Morgan Stanley

Equal-Weight → Overweight

Jun-25-18

Downgrade

Guggenheim

Buy → Neutral

Jun-25-18

Downgrade

Buckingham Research

Buy → Neutral

Jun-06-18

Initiated

Gabelli & Co

Buy

$95

Mar-03-21 09:25AM	CarMax to pay bonuses to more than 80% of its employee for efforts during 'challenging year' MarketWatch
09:00AM	CarMax Announces Bonuses for 22,000 Associates GlobeNewswire
Mar-02-21 12:10PM	Why CarMax (KMX) Could Beat Earnings Estimates Again Zacks
Feb-27-21 02:19PM	Multibagger Investor Chuck Akres Top 10 Stock Holdings Insider Monkey
Feb-26-21 07:00AM	This Hot Fund Likes Stocks Poised For The 'Real Economy' Rebound Investor's Business Daily
Feb-16-21 07:13AM	AutoNation blows away profit estimates, reveals $1 billion stock buyback plan Yahoo Finance
Feb-02-21 06:50AM	Save the Date: CarMax Analyst Day Thursday, May 6, 2021 Business Wire +5.24%
Feb-01-21 01:45AM	Our Take On The Returns On Capital At CarMax (NYSE:KMX) Simply Wall St.
Jan-26-21 11:36AM	3 Low Price-to-Median-Price-Sales Stocks to Consider GuruFocus.com +5.65%
Jan-22-21 11:01AM	5 Best Auto Stocks to Buy In 2021 InvestorPlace
Jan-21-21 11:30AM	CarMax (KMX) Up 31.8% Since Last Earnings Report: Can It Continue? Zacks
Jan-19-21 04:18PM	Stocks Close Higher, Near Day's Highs; Solar Stocks Extend Rally Investor's Business Daily +9.39%
Jan-18-21 08:28AM	Auto Stock Roundup: TSLA's India Entry, F's South America Restructuring & More Zacks
Jan-13-21 07:49AM	CarMax (KMX) Raises the Bar, Introduces Unique Consumer Offering Zacks
Jan-12-21 07:30AM	CarMax Launches New Signature Experience Industry-Leading Love Your Car Guarantee GlobeNewswire
Dec-31-20 07:12AM	The CarMax (NYSE:KMX) Share Price Has Gained 96% And Shareholders Are Hoping For More Simply Wall St.
Dec-28-20 06:10PM	Should You Buy CarMax After Pullback? GuruFocus.com
04:24PM	Lithia Motors, IBD Stock Of The Day, Is Back In Buy Zone After Close Call Investor's Business Daily
10:46AM	Auto Stock Roundup: THO's Tiffin Motorhomes Buyout, MGA-LG JV & More Zacks
Dec-24-20 07:12AM	CarMax Earnings: Growth Downshifts Motley Fool
Dec-23-20 09:39AM	Used-Car Retailer CarMax Shares Plunge Over 8% as COVID-19 Hurts Store Sales FX Empire
08:39AM	CarMax's (KMX) Q3 Earnings & Sales Beat Estimates, Up Y/Y Zacks
Dec-22-20 07:01PM	CarMax (KMX) Q3 2021 Earnings Call Transcript Motley Fool -8.09%
10:35AM	CarMax Falls as Earnings Beat Fails to Offset Lack of Guidance TheStreet.com
08:16AM	Peloton, Apple, Tesla, CarMax - Tuesday's Premarket Movers TheStreet.com
08:05AM	CarMax (KMX) Q3 Earnings and Revenues Top Estimates Zacks
07:15AM	CarMax, Inc. to Host Earnings Call ACCESSWIRE
07:13AM	CarMax's stock falls, as profit and revenue beat but same-store sales surprisingly declines MarketWatch
07:02AM	Recap: CarMax Q3 Earnings Benzinga
06:50AM	CarMax Reports Third Quarter Fiscal 2021 Results Business Wire
03:27AM	Apple, Peloton Rise in Premarket, CarMax Falls on Weak Sales Investing.com
Dec-21-20 10:06AM	CarMax Earnings Preview Benzinga
08:53AM	Idling in Carmax Could Be a Buying Opportunity TheStreet.com
08:49AM	FedEx, Oracle, CarMax, Paychex and JPMorgan are part of Zacks Earnings Preview Zacks
07:47AM	Tesla, CarMax, FactSet, and Other Stocks to Watch This Week Barrons.com
07:10AM	3 Things to Watch in the Stock Market This Week Motley Fool
Dec-20-20 03:08PM	Earnings Reports for the Week of Dec. 21-25 Kiplinger
09:22AM	Earnings to Watch in Holiday-Shortened Week: Heico, Carnival, CarMax, Cintas and Weibo in Focus FX Empire
Dec-17-20 11:00AM	CarMax Named Official Auto Retailer of the NBA and WNBA GlobeNewswire
Dec-15-20 12:30PM	CarMax (KMX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Dec-08-20 04:30PM	CarMax Announces Third Quarter Conference Call Business Wire
Dec-07-20 11:28AM	Is KMX A Good Stock To Buy Now? Insider Monkey
Nov-30-20 08:45AM	The CarMax Foundation to Donate up to $650,000 in Support of #GivingTuesday Campaign GlobeNewswire
Nov-22-20 03:18AM	Is CarMax, Inc.'s (NYSE:KMX) ROE Of 17% Impressive? Simply Wall St.
Nov-20-20 04:49PM	Cars that hold their value the best - and the worst Yahoo Finance Video
Nov-16-20 05:25PM	Akre Capital Management's Top 3rd-Quarter Trades GuruFocus.com
Oct-27-20 12:06PM	CarMax is Hiring for More Than 3,500 Positions by End of 2020 GlobeNewswire
10:26AM	Used car retailer Carlotz goes public Yahoo Finance Video
Oct-26-20 10:46PM	CarMax Inc (KMX): Are Hedge Funds Right About This Stock? Insider Monkey
12:04PM	Is CarMax (KMX) a Smart Long-term Buy? Insider Monkey
Oct-23-20 09:39AM	At US$91.42, Is CarMax, Inc. (NYSE:KMX) Worth Looking At Closely? Simply Wall St.
Oct-14-20 03:52PM	Mostly everyone is buying a new car during COVID-19: Shift.com co-CEO Yahoo Finance
Oct-09-20 08:42PM	Earnings Season Is About to Start. It Could Be Better Than You Think. Barrons.com
Oct-04-20 09:32AM	Notable Insider Buys Last Week: Blackstone, CarMax And More Benzinga
Oct-03-20 04:52PM	Top Insider Buys Highlight for the Week of Oct. 2 GuruFocus.com
Oct-02-20 11:32AM	Buy CarMax Stock Because Used Cars Are Hot, Says Morgan Stanley Barrons.com
09:51AM	Why CarMax Stock Fell 14% in September Motley Fool
06:16AM	Professional investors have their eye on these eight stocks as the used-car market in the U.S. moves online MarketWatch
Oct-01-20 01:53PM	Carvana's stock is up more than 160% this year its founder remains bullish Yahoo Finance
Sep-30-20 08:52AM	Why CarMax (KMX) Stock Might be a Great Pick Zacks
Sep-29-20 12:41PM	How Restaurants Are Starting to Come Back Motley Fool
11:33AM	5 Top Stocks to Buy in October Motley Fool
06:57AM	The Zacks Analyst Blog Highlights: Tesla, AutoZone, CarMax, Nikola Corp and Volkswagen Zacks
Sep-28-20 09:57AM	CarMax Restarts Share Buyback After 5 Months TheStreet.com
09:03AM	Auto Stock Roundup: TSLA Battery Day, AZO & KMX Earnings Beat and More Zacks
06:18AM	CarMax resumes share buybacks after suspending program in April due to pandemic MarketWatch
Sep-25-20 01:41PM	Carlotz Offers Unique Take on Used Car Play Beyond Pandemic IPO-Edge.com
Sep-24-20 08:00PM	CarMax (KMX) Q2 2021 Earnings Call Transcript Motley Fool -11.00%
06:07PM	S&P 500 Worries Its Way Higher on More Record Jobless Claims: Darden's New Dividend, Carmax Crash, United COVID Testing Motley Fool
04:14PM	CarMax Earnings Jump Unexpectedly As Used-Car Demand Revives In 'Seamless' Shopping Investor's Business Daily
01:18PM	CarMax Posts 2nd-Quarter Earnings and Revenue Beat GuruFocus.com
12:54PM	CarMax Stock Drops 13% Despite Beating Q2 Estimates Motley Fool
12:03PM	Stock Markets Gain Despite Economic Data; CarMax Cracks, Darden Delivers as Earnings Season Approaches Motley Fool
11:07AM	California moves to ban gas-powered cars Yahoo Finance Video
10:32AM	CarMax beats on profit, revenue expectations Yahoo Finance Video
10:28AM	CarMax's (KMX) Q2 Earnings & Sales Beat Estimates, Up Y/Y Zacks
10:05AM	CarMax Stock Dented After Results Beat Estimates TheStreet.com
09:45AM	CarMax (KMX) Q2 Earnings and Revenues Surpass Estimates Zacks
09:23AM	Largest Used Car Retailer Completes Roll Out of Online Car Buying Nationwide Business Wire
07:05AM	CarMax: Q2 Earnings Insights Benzinga
07:00AM	CarMax, Inc. to Host Earnings Call ACCESSWIRE
06:50AM	CarMax Reports Record Second Quarter Fiscal 2021 Results Business Wire
Sep-23-20 10:55AM	CarMax (KMX) to Report Q2 Earnings: What's in the Cards? Zacks
10:07AM	Earnings Outlook for CarMax Benzinga
09:50AM	A Look At CarMax's (NYSE:KMX) CEO Remuneration Simply Wall St.
Sep-22-20 12:28PM	Carvana Stock Soars Because No One Knew Demand for Used Cars Would Be So Good Barrons.com
Sep-21-20 02:18PM	CarMax Looks Vulnerable on the Charts TheStreet.com
Sep-20-20 07:22PM	Tesla's Battery Day, Powell appears before Congress: What to know in the week ahead Yahoo Finance
03:00PM	Nike, Costco, General Mills, and Other Stocks for Investors to Watch This Week Barrons.com
Sep-17-20 12:30PM	CarMax (KMX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Sep-15-20 01:09PM	CarMax Hits Key Rating Benchmark After Stock Nearly Triples Investor's Business Daily
Sep-14-20 08:00PM	Technical Assessment: Bullish in the Intermediate-Term Argus Research
Sep-11-20 07:27AM	How to Get the Best Trade-in Value for Your Old Car TheStreet.com
Sep-10-20 04:30PM	CarMax Announces Second Quarter Conference Call Business Wire
Sep-09-20 08:00PM	Seeking Direction After Hot Summer Argus Research
08:00PM	Daily Spotlight: Argus Adjusts Sector Ratings Argus Research
09:28AM	Why CarMax Stock Rose 10% in August Motley Fool
Sep-08-20 10:40AM	CarMax Inc (KMX): Hedge Funds Are Snapping Up Insider Monkey
Sep-03-20 01:43PM	Why You Need to Pay Attention to the Exxon Mobil Stock Selloff InvestorPlace
Aug-24-20 01:16PM	Returns On Capital At CarMax (NYSE:KMX) Paint An Interesting Picture Simply Wall St.

CarMax, Inc., through its subsidiaries, operates as a retailer of used vehicles in the United States. The company operates in two segments, CarMax Sales Operations and CarMax Auto Finance. It offers customers a range of makes and models of used vehicles, including domestic, imported, and luxury vehicles; vehicles that do not meet its retail standards to licensed dealers through on-site wholesale auctions; and extended protection plans to customers at the time of sale. The company also provides reconditioning and vehicle repair services; and financing alternatives for retail customers across a range of credit spectrum through its CarMax Auto Finance and arrangements with various financial institutions. As of February 29, 2020, it operated approximately 216 stores and 2 new car franchises. CarMax, Inc. was founded in 1993 and is based in Richmond, Virginia.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Daniels Jon G	SVP, CAF	Feb 08	Option Exercise	51.63	20,129	1,039,260	21,609	Feb 10 05:15 PM
Daniels Jon G	SVP, CAF	Feb 08	Sale	127.54	20,129	2,567,341	1,480	Feb 10 05:15 PM
Mayor-Mora Enrique N	SVP & CFO	Feb 05	Option Exercise	58.38	10,902	636,459	17,416	Feb 08 04:50 PM
Mayor-Mora Enrique N	SVP & CFO	Feb 05	Sale	126.31	9,147	1,155,358	8,269	Feb 08 04:50 PM
Hill Edwin J	EVP & COO	Jan 21	Option Exercise	58.38	35,000	2,043,300	43,258	Jan 22 04:41 PM
Hill Edwin J	EVP & COO	Jan 21	Sale	120.70	35,000	4,224,583	8,258	Jan 22 04:41 PM
Mayor-Mora Enrique N	SVP & CFO	Jan 20	Option Exercise	58.38	9,000	525,420	14,386	Jan 22 04:41 PM
Newberry Darren C	SVP	Jan 20	Option Exercise	60.04	20,175	1,211,221	25,756	Jan 22 04:42 PM
Nash William D	President & CEO	Jan 20	Option Exercise	53.62	100,000	5,362,000	217,000	Jan 22 04:42 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jan 20	Option Exercise	58.38	20,000	1,167,600	42,440	Jan 22 04:41 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jan 20	Sale	123.82	20,000	2,476,400	22,440	Jan 22 04:41 PM
Newberry Darren C	SVP	Jan 20	Sale	124.01	20,175	2,501,948	5,581	Jan 22 04:42 PM
Nash William D	President & CEO	Jan 20	Sale	123.14	100,000	12,313,652	117,000	Jan 22 04:42 PM
Mayor-Mora Enrique N	SVP & CFO	Jan 20	Sale	117.08	7,872	921,654	6,514	Jan 22 04:41 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jan 14	Option Exercise	58.38	15,000	875,700	37,440	Jan 15 04:38 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jan 14	Sale	106.68	15,000	1,600,200	22,440	Jan 15 04:38 PM
Nash William D	President & CEO	Jan 12	Option Exercise	51.63	58,674	3,029,339	175,674	Jan 14 05:14 PM
Hill Edwin J	EVP & COO	Jan 12	Option Exercise	51.63	47,096	2,431,566	55,354	Jan 14 05:14 PM
Cafritz Diane L	SVP & CHRO	Jan 12	Option Exercise	62.01	17,861	1,107,569	22,507	Jan 14 05:14 PM
Reedy Thomas W JR	EVP of Finance	Jan 12	Option Exercise	73.76	35,321	2,605,277	55,300	Jan 14 05:15 PM
Reedy Thomas W JR	EVP of Finance	Jan 12	Sale	106.04	35,321	3,745,439	19,979	Jan 14 05:15 PM
Cafritz Diane L	SVP & CHRO	Jan 12	Sale	106.32	17,861	1,898,982	4,646	Jan 14 05:14 PM
Hill Edwin J	EVP & COO	Jan 12	Sale	106.11	47,096	4,997,357	8,258	Jan 14 05:14 PM
Nash William D	President & CEO	Jan 12	Sale	106.23	58,674	6,232,939	117,000	Jan 14 05:14 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jan 08	Option Exercise	58.38	15,000	875,700	39,440	Jan 11 04:34 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jan 08	Sale	102.51	15,000	1,537,650	24,440	Jan 11 04:34 PM
Reedy Thomas W JR	EVP of Finance	Dec 30	Sale	93.53	14,647	1,369,934	19,979	Dec 30 05:43 PM
ONeil Mark F	Director	Sep 30	Buy	93.40	2,700	252,180	5,709	Oct 02 04:15 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Aug 10	Option Exercise	53.60	8,863	475,037	33,303	Aug 11 05:33 PM
Reedy Thomas W JR	EVP of Finance	Aug 10	Option Exercise	68.14	74,220	5,057,459	108,846	Aug 11 05:33 PM
Reedy Thomas W JR	EVP of Finance	Aug 10	Sale	102.18	74,220	7,583,800	34,626	Aug 11 05:33 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Aug 10	Sale	102.11	8,863	905,001	24,440	Aug 11 05:33 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Aug 07	Option Exercise	51.63	15,124	780,852	39,564	Aug 11 05:33 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Aug 07	Sale	100.26	15,124	1,516,332	24,440	Aug 11 05:33 PM
Lyski James	EVP & Chief Marketing Officer	Aug 04	Option Exercise	63.06	73,235	4,618,345	81,678	Aug 05 04:17 PM
Lyski James	EVP & Chief Marketing Officer	Aug 04	Sale	99.40	73,235	7,279,559	8,443	Aug 05 04:17 PM
Daniels Jon G	SVP, CAF	Jul 23	Option Exercise	73.76	21,717	1,601,846	23,197	Jul 27 04:20 PM
Daniels Jon G	SVP, CAF	Jul 23	Sale	99.25	21,717	2,155,442	1,480	Jul 27 04:20 PM
FOLLIARD THOMAS J	Director	Jul 22	Option Exercise	73.76	254,731	18,788,959	466,687	Jul 23 04:38 PM
Cafritz Diane L	SVP & CHRO	Jul 22	Option Exercise	51.63	3,000	154,890	11,208	Jul 23 04:38 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jul 22	Option Exercise	73.76	33,026	2,435,998	57,466	Jul 23 04:38 PM
Livesay Jill A	VP, Controller & PAO	Jul 22	Sale	98.00	2,107	206,486	4,933	Jul 23 04:38 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jul 22	Sale	97.89	33,026	3,232,915	24,440	Jul 23 04:38 PM
FOLLIARD THOMAS J	Director	Jul 22	Sale	97.61	254,731	24,863,310	211,956	Jul 23 04:38 PM
Cafritz Diane L	SVP & CHRO	Jul 22	Sale	97.09	6,562	637,105	4,646	Jul 23 04:38 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jul 21	Option Exercise	73.76	5,781	426,407	30,221	Jul 23 04:38 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jul 21	Sale	96.12	5,781	555,670	24,440	Jul 23 04:38 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jul 17	Option Exercise	73.76	12,525	923,844	36,965	Jul 20 04:56 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jul 17	Sale	95.76	12,525	1,199,394	24,440	Jul 20 04:56 PM
Hill Edwin J	EVP & COO	Jul 16	Option Exercise	63.55	97,532	6,198,110	109,568	Jul 20 04:56 PM
Hill Edwin J	EVP & COO	Jul 16	Sale	95.04	101,310	9,628,299	8,258	Jul 20 04:56 PM
Daniels Jon G	SVP, CAF	Jul 15	Option Exercise	73.76	21,717	1,601,846	27,448	Jul 17 04:16 PM
Daniels Jon G	SVP, CAF	Jul 15	Sale	94.02	25,968	2,441,511	1,480	Jul 17 04:16 PM
BLAYLOCK RONALD E	Director	Jul 13	Sale	89.37	10,200	911,574	17,046	Jul 15 06:12 PM
Mayor-Mora Enrique N	SVP & CFO	Jun 23	Option Exercise	61.97	41,100	2,546,955	42,886	Jun 25 05:05 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jun 23	Option Exercise	73.76	1,200	88,512	25,640	Jun 25 05:04 PM
Wilson Charles Joseph	SVP	Jun 23	Option Exercise	63.65	39,085	2,487,707	45,603	Jun 25 05:06 PM
Shamim Mohammad	SVP and CIO	Jun 23	Option Exercise	51.63	15,782	814,825	24,337	Jun 25 05:05 PM
Reedy Thomas W JR	EVP of Finance	Jun 23	Option Exercise	54.79	48,267	2,644,528	88,323	Jun 25 08:32 PM
Reedy Thomas W JR	EVP of Finance	Jun 23	Sale	92.50	53,697	4,966,746	34,626	Jun 25 08:32 PM
Shamim Mohammad	SVP and CIO	Jun 23	Sale	91.87	15,782	1,449,847	8,555	Jun 25 05:05 PM
Wilson Charles Joseph	SVP	Jun 23	Sale	92.46	39,085	3,613,786	6,518	Jun 25 05:06 PM
MARGOLIN ERIC M	EVP, Gen. Counsel & Secretary	Jun 23	Sale	94.32	1,200	113,184	24,440	Jun 25 05:04 PM
Mayor-Mora Enrique N	SVP & CFO	Jun 23	Sale	92.15	37,500	3,455,546	5,386	Jun 25 05:05 PM
Goodman Shira	Director	Apr 17	Buy	63.91	1,550	99,061	26,439	Apr 21 04:17 PM

open in screener | open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience